跳至主要内容
临床试验/NCT00524680
NCT00524680已完成2 期

Study of Serum 25(OH) D3 Level Variability in Response to Different Doses of Oral Vitamin D Supplementation in Prostate Cancer Patients

Roswell Park Cancer Institute2 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2007年6月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
148
试验地点
2
主要终点
Pattern of Response of Serum 25(OH) D3 Levels

研究概览

简要总结

RATIONALE: Vitamin D may be effective in treating patients with prostate cancer.

PURPOSE: This randomized phase II trial is studying how well 4 different doses of vitamin D works in treating patients with prostate cancer.

详细描述

OBJECTIVES:

Primary

  • To examine the pattern of response of serum 25(OH) D3 levels following cholecalciferol (vitamin D3) supplementation at four different oral doses in patients with prostate cancer.

Secondary

  • To examine the pattern of response of parathormone (PTH) following vitamin D3 supplementation in these patients.
  • To assess the toxicity of vitamin D3 supplementation in men with prostate cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Pattern of Response of Serum 25(OH) D3 Levels

时间窗: Baseline, at 1, 3, 6 months

Change from Baseline in Serum 25(OH) D3 Levels at 1, 3, and 6 Months at dose levels 4000, 6000, 8000 and 10000 IU. Statistical analysis was done using one sample t-test.

次要结局

  • Toxicity(Baseline, at 1, 3 and 6 months)
  • Pattern of Response of Parathormone(Baseline, at 1, 3, 6 months)
  • Occurrence of Infections, Deep Vein Thrombosis, Vascular Events, and Falls(Baseline, at 1, 3 ,6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验